Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Protalix BioTherapeutics Inc.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-04-11
Purchase
2022-04-13
4:05 pm
Protalix BioTherapeutics Inc. PLX Bashan Dror
CEO
68,000 $1.5 $102,000 1,153,458
(Indirect
Direct)
View
2021-06-02
Sale
2021-06-03
5:40 pm
Protalix BioTherapeutics Inc. PLX Dexcel Pharma Technologies Ltd.
Oren Dan
10% Owner
918,717 $2.2737 $2,088,857 3,637,314
(Direct)
View
2020-04-07
Purchase
2020-04-13
4:05 pm
Protalix BioTherapeutics Inc. PLX Schwartz Aharon
Director
64,000 $2.426 $155,264 64,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-30
Option Award
2022-07-05
4:32 pm
N/A
2032-06-30
Protalix BioTherapeutics Inc. PLX Ben Zvi Shmuel
Director
40,000 $0 40,000
(Direct)
View
2022-02-25
Option Award
2022-02-28
5:02 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Rubin Eyal
CFO
121,951 $0 368,097
(Indirect)
View
2022-02-25
Option Award
2022-02-28
5:01 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Bashan Dror
CEO
637,531 $0 1,085,458
(Indirect)
View
2021-02-12
Ownership
2021-02-16
12:07 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Dexcel Pharma Technologies Ltd.
Oren Dan
10% Owner
0 $0 7,372,932
(Direct)
View
2020-08-11(A)
Option Award
2020-08-14
5:01 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Rubin Eyal
CFO
246,146 $0 246,146
(Indirect)
View
2020-08-11(A)
Option Award
2020-08-14
5:01 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Bashan Dror
CEO
447,927 $0 447,927
(Indirect)
View
2020-08-11
Option Award
2020-08-13
5:03 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Rubin Eyal
CFO
246,146 $0 246,146
(Indirect)
View
2020-08-11
Option Award
2020-08-13
5:02 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Bashan Dror
CEO
447,927 $0 447,927
(Indirect)
View
2020-08-11
Option Award
2020-08-13
5:01 pm
N/A
2030-08-11
Protalix BioTherapeutics Inc. PLX Naos Yaron
VP
122,656 $0 122,656
(Direct)
View
2020-07-05
Option Award
2020-07-08
5:01 pm
N/A
2030-07-05
Protalix BioTherapeutics Inc. PLX Hayon Yael
VP
129,771 $0 129,771
(Direct)
View
2020-06-07
Option Award
2020-06-08
5:07 pm
N/A
2030-06-07
Protalix BioTherapeutics Inc. PLX Almon Einat Brill
SVP Chief Development Officer
196,995 $0 196,995
(Direct)
View
2020-02-03
Option Award
2020-02-05
5:01 pm
N/A
2030-02-03
Protalix BioTherapeutics Inc. PLX Bronfeld Zeev
Director
240,000 $0 240,000
(Direct)
View
2020-01-20
Option Award
2020-01-22
5:03 pm
N/A
2030-01-20
Protalix BioTherapeutics Inc. PLX Granot David
Director
40,000 $0 40,000
(Direct)
View
2020-01-20
Option Award
2020-01-22
5:03 pm
N/A
2030-01-20
Protalix BioTherapeutics Inc. PLX Bar-Shalev Amos
Director
40,000 $0 40,000
(Direct)
View
2020-01-20
Option Award
2020-01-22
5:02 pm
N/A
2030-01-20
Protalix BioTherapeutics Inc. PLX Schwartz Aharon
Director
40,000 $0 40,000
(Direct)
View
2020-01-20
Option Award
2020-01-22
5:02 pm
N/A
2030-01-20
Protalix BioTherapeutics Inc. PLX Boudes Pol F
Director
40,000 $0 40,000
(Direct)
View
2020-01-20
Option Award
2020-01-22
5:01 pm
N/A
2030-01-20
Protalix BioTherapeutics Inc. PLX Melincoff Gwen A
Director
40,000 $0 40,000
(Direct)
View
2020-01-01
Ownership
2020-01-03
5:15 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Boudes Pol F
Director
0 $0 40
(Direct)
View
2019-09-22
Option Award
2019-09-24
5:01 pm
N/A
2029-09-22
Protalix BioTherapeutics Inc. PLX Rubin Eyal
CFO
800,000 $0 800,000
(Direct)
View
2019-06-30
Option Award
2019-07-02
5:56 pm
N/A
2029-06-30
Protalix BioTherapeutics Inc. PLX Bashan Dror
CEO
1,600,000 $0 1,600,000
(Direct)
View
2018-09-13
Option Award
2018-09-14
4:31 pm
N/A
2028-09-13
Protalix BioTherapeutics Inc. PLX Maimon Yossi
CFO
700,000 $0 700,000
(Direct)
View
2018-09-13
Option Award
2018-09-14
4:31 pm
N/A
2028-09-13
Protalix BioTherapeutics Inc. PLX Almon Einat Brill
VP
700,000 $0 700,000
(Direct)
View
2018-09-13
Option Award
2018-09-14
4:30 pm
N/A
2028-09-13
Protalix BioTherapeutics Inc. PLX Naos Yaron
VP
600,000 $0 600,000
(Direct)
View
2018-09-13
Option Award
2018-09-14
4:30 pm
N/A
2028-09-13
Protalix BioTherapeutics Inc. PLX Manor Moshe
CEO
1,300,000 $0 1,300,000
(Direct)
View
2018-09-13
Option Award
2018-09-14
4:30 pm
N/A
2028-09-13
Protalix BioTherapeutics Inc. PLX Shaaltiel Yoseph
VP
700,000 $0 700,000
(Direct)
View
2018-05-29
Ownership
2018-06-08
4:07 pm
N/A
N/A
Protalix BioTherapeutics Inc. PLX Naos Yaron
VP
0 $0 414,563
(Direct)
View
(A) Indicate amendment filing.